Last reviewed · How we verify

NCT03889353: GHOST

Brain Computer Interface and Virtual Reality (BCI-VR) for Pain Treatment

Completed NA Last updated 21 April 2022
What this trial tests

NA trial testing BCI sessions in Neuropathic Pain in 7 participants. Completed in 9 November 2021.

Timeline
9 May 2019
Primary endpoint
9 May 2021
9 November 2021

Quick facts

Lead sponsorNantes University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment7
Start date9 May 2019
Primary completion9 May 2021
Estimated completion9 November 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

Adults 18 to 70, any sex, with Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pilot Interventional study with minimal risks and constraints, prospective, monocentric. Safety and Efficacity evaluation of a Novel Medical Device.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. EEG-based brain-computer interface with immersive virtual reality for phantom limb pain: a single-center pilot neurofeedback trial.
    Roualdes V, Moussaoui S, Normand JM, Kuhn E, et al · · 2026 · PMID 42022239 · DOI 10.3389/fnhum.2026.1697837

Verify or expand the search:

Other recruiting trials for Neuropathic Pain

Currently open trials in the same condition.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03889353.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing